The Pandemic’s Impact on B2B Selling

Buying and selling changed dramatically in the last year, accelerated by the pandemic, forcing both parties to use digital channels. Back to discuss COVID-19’s influence on global selling, Christoph Schell, Chief Commercial Officer at HP, talked with Calvary TV host Joe Gemma.

The second conversation focuses on eCommerce, social selling, omnichannel and other paradigm shifts.

Schell described HP’s response. “There is a decentralization of decision-making, and the shopping journey moved online for B2B. Regions don’t work anymore; it’s a global strategy to ensure consistency.”

HP redefined its sales process and included centers of excellence. The two most critical are the HP store, where customers interact directly with the brand, and building an omnichannel team. “The customer is getting more information and leaving footprints, which we use to understand what they want, sometimes before they articulate it. That’s caused me to hire data analysts in sales,” Schnell said.

More data about customers offers companies the chance to have one-on-one engagement and more personalized experiences. A global message is the bedrock, but Schnell noted that localization in individual markets customizes it.

Schnell also spoke about forecasting. “Historical data wasn’t important last year. We went to scenarios looking at the accuracy of ambition of what we want to achieve. It’s a bigger focus on outcomes.”

How people sell is different now, too. Schnell thinks that some traditional approaches will remain, but that social selling and data analytics will thrive. “Social selling works. It’s relationship-building –virtually. Both traditional and social will co-exist, but the pandemic accelerated digital channels.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More